- New studies support flexible dosing and co-administration with flu vaccine
You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists and analysts/investors.
Regulatory submissions in the EU and Canada remain on track for 2016
GSK announces US regulatory submission for sirukumab in rheumatoid arthritis
GSK announces regulatory submissions for subcutaneous formulation of Benlysta® (belimumab) for patients with systemic lupus disease
It has filed regulatory submissions in the US and Europe for Benlysta® (belimumab) for approval.